ABSTRACT. Expression of 150 kda oxygen-regulated protein, ORP150, was examined in the atheromatous lesions on aortic valves in highfat diet fed mice. Immunohistochemical staining revealed that ORP150 was expressed on the surface of plaque and was co-localized with phagocytes bearing Mac-3, a mouse macrophage differentiation antigen. These findings suggest that ORP150 is involved in the development of the atheromatous plaque. Titer of autoantibody against ORP150 was gradually elevated in parallel with the length of period of high-fat diet feeding. These results suggest that the deposition of immunocomplex toward ORP150 antigen is involved in atheromatous plaque progression. KEY WORDS: atheroma, autoantigen, ORP150.
ORP150, 150 kda oxygen-regulated protein, is a member of glucose regulated proteins (GRPs), which is known to be localized in the endoplasmic reticulum (ER) and is induced by glucose-and/or oxygen-deprived conditions, especially ischemic environments [7, 10] . Oxygen concentration is known to be reduced in atherosclerotic plaques [1] . ORP150 is highly expressed in the atherosclerotic lesions of human patients whose sera exhibit highly increased titers of anti-ORP150 autoantibody [15] . These findings suggested that ORP150 may be an appropriate indicator of vascular lesions, especially of atherosclerosis. However, the patients under investigation in the previous report were relatively old in age and few in number, and they may have been affected by factors including medication or other complications. Here, we report on the ORP150 antigen expression and the elevated autoantibody against ORP150 in an experimental mouse atheroma model induced by high-fat diet.
Female C57BL/6J mice were purchased from Japan Clea (JCL, Tokyo, Japan) at 4 weeks of age, divided into two groups, and caged in a conventionally conditioned animal care facility with 7:00 a.m. to 7:00 p.m. period of light, controlled room temperature (24-27°C) and humidity (55 ± 5%). Control basic diet CE2 was purchased from JCL. High-fat diet was prepared by JCL according to the recipe (1.25% cholesterol, 7.5% cocoa butter, 7.5% milk casein and 0.5% sodium cholate in basic diet CE2) and provided as pellets [8, 14] . Starting from 5 weeks of age, one group was fed on high-fat diet (n=6) and the other on basic diet (n=5). After 5, 10 and 15 weeks of feeding, blood samples were obtained from orbital sinus under diethyl ether anesthesia, and sera were separated. After the last blood sampling, mice were killed by cervical dislocation and hearts were removed and fixed in 4% paraformaldehyde. Experiments were performed in accordance with the Japanese law concerning the protection and control animals and the guidelines for animal experimentation through a scientific and ethical consensus of the Japanese Association for Laboratory Animal Science.
An antigen for ELISA to detect ORP150 autoantibodies was prepared by Escherichia coli. Partial human ORP150 cDNA (XmnI fragment; encodes 482 amino acids of the amino terminal half) was ligated to the pGEX-2TK (Pharmacia Biotech, Uppsala, Sweden) in frame, and used for transformation of Escherichia coli BL21 (Pharmacia). After induction of GST-ORP150 by isopropyl-beta-D-1-thiogalactopyranoside (Pharmacia), the cells were sonicated and centrifuged, and the supernatant was collected. Recombinant GST-ORP150 was purified by affinity chromatography according to the manufacturer's instructions. Protein was assayed by a BCA protein assay kit (Pierce, Rockford, IL, U.S.A.) and used as the antigen for ELISA. To prepare anti-ORP150 antiserum from mouse for standard of ELISA, an mouse was immunized with this antigen and adjuvant for 4 weeks, and serum was separated.
The antigen dissolved in bicarbonate buffer (pH 9.8) was absorbed onto microtiter wells of ELISA plates (Maxisorp, Nunc, Rochester, NY, U.S.A.) and incubated overnight at 4°C, followed by blocking with phosphate-buffered saline (PBS) containing 0.1% bovine serum albumin (BSA) under the same condition. After washing with PBS containing Tween 20 (0.1%), serum samples diluted serially 1:20 with assay buffer (PBS containing 10% fetal bovine serum and 1% BSA) were applied and incubated overnight at 4°C. After washing, plates were incubated with anti-mouse IgG (Biosource International, Camarillo, CA, U.S.A., 1:1,000 diluted with assay buffer) for 1 hr at room temperature. After final washing and incubation with 3,3',5,5'-tetramethylbenzidine substrate reagent (KPL, Gaithersburg, MD,U.S.A.) for 5 min at room temperature, reaction was stopped by 1N HCl and optical density was measured at 450 nm with a plate reader.
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Snap frozen tissues in OCT compound were serially sectioned in a cryostat at 5 µm thickness. Each section was either stained with Sudan III or immunostained with rabbit polyclonal antibody against human ORP150 [16] , human factor VIII (A-0082, DAKO, Carpinteria, CA, U.S.A.) or mouse monoclonal antibody against Mac-3 (M3/84, Pharmingen, San Diego, CA, U.S.A.) or anti-α-smooth muscle actin (α-SMA, 1A4, DAKO). ORP150 localization was detected using PAP kit (DAKO) with porcine polyclonal anti-rabbit IgG for second antibody and others were detected using LSAB kit (DAKO) with goat polyclonal anti-rabbit (factor VIII), anti-rat (Mac-3) or anti-mouse (α-SMA) IgG. Simultaneously, normal rabbit, rat or mouse serum (Biomeda, Hayward, CA, U.S.A.) was used in each immunostaining instead of first antibody and confirmed that all slides were not detected the nonspecific staining.
Data were analyzed by Dunnett's t test with a statistical software package, StatView 5.0 (SAS Institute Inc., Cary, NC). Differences between means at the P<0.05 level were considered significant.
After 15-weeks feeding of high-fat diet to female C57BL/ 6J mice, atheroma was formed on aortic valve leaflets (Fig.  1A) , whereas it was not formed in basic chow diet feeding mice (Fig. 1B) . Sudan III stain revealed that deposition of lipids was especially marked in the plaques (Fig. 2A) . These results seemed to justify the use of this model mouse for the study of atheroma.
Immunohistochemical study revealed that ORP150 was expressed on the plaque, especially on the surface (Fig. 2B) . Its localization was similar to that of Mac-3 protein (Fig.  2C) , which is a marker of differentiated macrophages, but not to α-SMA or factor VIII, which is a marker of smooth muscle cells or endothelial cells, respectively (data not shown). Therefore, ORP150 was expressed in differentiated macrophage on the plaques.
In preliminary studies, the linearity of ELISA of ORP150 was confirmed using with serial dilutions of mouse anti-ORP150 serum. After 5-week feeding of high-fat diet, the levels of ORP150 autoantibody were increased against the basic diet-fed mice and reached maximum at 10 weeks. The high levels of ORP150 autoantibody continued up to 15 weeks, showing a significant increase (Fig. 3) .
High-fat diet-fed mouse is well characterized model for study of human atheroma [13] . In this study, we demonstrated that ORP150 was expressed in atheromatous plaques formed by high-fat diet feeding, especially in Mac-3 positive cells on the atheroma surface. Oxygen concentration is reduced in deep part of plaques [1] and low oxygen-tension induces ORP150 expression [7, 10] . Therefore, we expected ORP150 expression in deep part of plaques, but the above results were apparently inconsistent with the previous finding [15] . Human plaque may result from a variety of events for long life, including vascular smooth muscle cell proliferation, matrix formation, and fibrous cap formation [12] . On the other hand, lipid-rich atheroma, similar to that seen in the present model mice, is thought to be at an initial stage of plaque formation. Therefore, the difference in plaque size might account for the discrepancy in localization of ORP150 expression. Next, Mac-3 positive cells were present on the surface of plaque, and cells reacting to ORP150 were co-localized with Mac-3 positive cells. It is reported that ORP150 is expressed in mononuclear phagocytes of human atheromatous plaques, and that the expression is enhanced in cultured macrophages by addition of modified low density lipoprotein (LDL) [15] . High-fat feeding increases serum LDL level [14] , which in turn produces modified LDL from endothelial cells [4] , and converts mononuclear macrophages to foam cells through LDL-receptors binding to the modified LDL [2] . Because surface of plaques is exposed to modified LDL, such a environment may facilitate this conversion. Mac-3 is known to be expressed in differentiated mouse macrophages [5] . Therefore, similar to previous finding [12] , ORP150 must be expressed in LDL-loaded macrophages, namely foam cells.
Why do foam cells express high levels of ORP150? ORP150 is human homologue of GRP170, which is a member of GRPs [4] . GRP78, which is representative protein of GRPs, is known to bind to some secretory protein or malfolded protein and assist the correct folding [2, 3, 7, 8, 13] . ORP150/GRP170 binds to immunoglobulin, thyroglobulin, thrombospondin or GP80/clusterin as secretory proteins [1, 5, 6] and abundant expression is observed in some secretory tissues such as pancreas and liver under normoxic environment [7] . Furthermore, ORP150 overexpression promotes the secretion of vascular endothlial growth factor (VEGF) and inhibition of ORP150 expression decreases secretion of VEGF [9, 10] . Foam cells, which are mononuclear macrophages uptaked oxidatively modified LDL (Ox-LDL), expresses VEGF [11] , which induces migration and proliferation of endothelial cells and develops the atheromatous plaques. Therefore, it seemed that ORP150 expression in foam cells is due to the increased secretion of VEGF.
The elevation of anti-ORP150 autoantibody was observed with high-fat feeding. Diet recipe used in this study was based on previous report [8, 14] . In previous report of the increment anti-ORP150 autoantibody in human atherosclerotic patients, it was discussed the possibility of the relation of plaque rupture and ORP150 as indicator of vascular biology. But high-fat diet feeding in this study may induce liver disorder, thus, autoantigen might be derived from hepatocytes because of abundant expression of ORP150. Addition to the expression of ORP150 on the atheroma surface, anti-ORP150 autoantibody was increased by the high-fat diet feeding. Thus, the deposition of ORP150 immunocomplex on the atheroma surface may be one of a factor of progression of atheromatous plaques.
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